Replies to post #47124 on CV Sciences Inc (CVSI)

[jefra1965]

It was my understanding that the GRAS study that CVSI had done last summer was in line with FDA protocols.....there would be no point in doing such and paying for a toxicology report that would not meet FDA standards.

First of all thanks for your post. I'm sure all posters here look forward to reading your posts. Now, I understand that the work done by CVSI exceeds the FDA standards.
Personally I believe that the FDA is stalling the CBD rulings for as long as they can. Maybe the new director will change that in our favor. I believe this is the case because CBD is nothing new to the FDA. The FDA have had enough time to come up with something even basic. They knew the FB was coming and they have the tools such as the FDA GRAS certification to enforce whatever they needed to enforce.

In other words, the FDA could had broken down the CBD market in several categories long time ago. Topicals, low concentration extracts, edibles, vape pens and high concentration CBD (Pharma) . Apply the tools they already have to issue some basic guidance and get this moving in the mean time without having to wait for the Senate or Congress to tell them to get something done.

Now they say (FDA) we will have a hearing in two months??? They could have announced the hearing to be held this months since January. They are buying time and they will keep doing it. For whom?? I don't know but they are.

_________________________________________________

The FDA is going to have to determine what is safe and why they think your product is safe.

We are clearly in the drivers seat on this......way ahead of competitors..

Often times, in these situations, its a company's R and D that is ahead of the curve wins.

Some company is going to be the first to get approval.

I like our chances.....

The only problem with this is that the rest of the industry is catching up and there is only a specific time frame to take advantage of your leadership position. On a positive note, CVSI is already working on the efficacy of it's products according to Tomc's interviews. And it looks like the company will be moving the development of the CVSI-007 forward this year. I hope I'm wrong and the new FDA director takes a more expeditious approach. Or the Senate or Congress take action soon.

I want Gottlieb to be gone TODAY.

[SpaceLady]

I appreciate your post and clarity. I am in agreement, that we are ahead of the curve at this point, but I am also concerned that the FDA is deliberately dragging it feet on this.
My hope is that the FDA, congress or the States take action soon to clear this mess up and allow good companies to advance. I do not like that our advantage is being diminished on a daily basis. this stock is still feeling the effects of Andrew Left's short attack, with all of it's aftereffects.
Keep your posts coming!

[mc73]

Agree!